About
Antibody and diagnostic for dpp3, a biomarker of short-term organ dysfunction
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
154
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06832722Lead Sponsor
Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
PHASE1/PHASE2Recruiting
130 participants
Started: Jul 13, 2025 · Completed: Apr 1, 2026
NCT06331884Lead Sponsor
Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)
PHASE1Completed
24 participants
Started: Mar 7, 2024 · Completed: Sep 4, 2024
Locations (1)
Headquarters
Hennigsdorf, Germany
Map
Loading map...